| CTRI Number |
CTRI/2025/02/079861 [Registered on: 03/02/2025] Trial Registered Prospectively |
| Last Modified On: |
30/01/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Case Control Study |
| Study Design |
Other |
|
Public Title of Study
|
Accuracy of Systemic Inflammatory Markers in identifying Neonatal Sepsis |
|
Scientific Title of Study
|
Accuracy of Systemic Inflammatory Indices in identifying Neonatal Sepsis in preterms in a tertiary care hospital in Mangalore |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| - |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Smrithi GM |
| Designation |
MBBS Intern |
| Affiliation |
Kasturba Medical College, Mangalore |
| Address |
Department of Pediatrics,
Kasturba Medical College,
Mangalore - 575001.
Dakshina Kannada KARNATAKA 575001 India |
| Phone |
9176738968 |
| Fax |
|
| Email |
smrithi.g@learner.manipal.edu |
|
Details of Contact Person Scientific Query
|
| Name |
Gayathri Renganathan |
| Designation |
Assistant Professor |
| Affiliation |
Kasturba Medical College, Mangalore |
| Address |
Department of Pediatrics,
Kasturba Medical College,
Mangalore - 575001.
Dakshina Kannada KARNATAKA 575001 India |
| Phone |
9632866222 |
| Fax |
|
| Email |
gayathri.renganathan@manipal.edu |
|
Details of Contact Person Public Query
|
| Name |
Gayathri Renganathan |
| Designation |
Assistant Professor |
| Affiliation |
Kasturba Medical College, Mangalore |
| Address |
Department of Pediatrics,
Kasturba Medical College,
Mangalore - 575001.
Dakshina Kannada KARNATAKA 575001 India |
| Phone |
9632866222 |
| Fax |
|
| Email |
gayathri.renganathan@manipal.edu |
|
|
Source of Monetary or Material Support
|
| Government Lady Goschen Hospital, Mangaluru, Karnataka - 575001, India. |
|
|
Primary Sponsor
|
| Name |
Smrithi GM |
| Address |
Department of Pediatrics,
Kasturba Medical College,
Mangalore - 575001, Karnataka, India. |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Smrithi GM |
Government Lady Goschen Hospital |
Neonatal Intensive Care Unit (NICU),
Third floor,
Government Lady Goschen Hospital, Mangaluru,
Dakshina Kannada,
Karnataka - 575001,
India. Dakshina Kannada KARNATAKA |
9176738968
smrithineha@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, Kasturba Medical College, Mangalore |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: A419||Sepsis, unspecified organism, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
NIL intervention |
NIL intervention |
|
|
Inclusion Criteria
|
| Age From |
1.00 Day(s) |
| Age To |
28.00 Day(s) |
| Gender |
Both |
| Details |
Preterm neonates in NICU |
|
| ExclusionCriteria |
| Details |
i. Term Neonates admitted to NICU.
ii. Healthy newborns in postnatal wards.
iii. Not willing to participate.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Assess the value of lab based diagnostic indices in early diagnosis of neonatal sepsis in preterms |
Evaluate lab based diagnostic indices, taken 24 hours after birth. |
|
|
Secondary Outcome
|
|
|
Target Sample Size
|
Total Sample Size="138" Sample Size from India="138"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
10/02/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="4" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identiļ¬cation.
- What additional supporting information will be shared?
Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Proposals should be directed to [smrithi.g@learner.manipal.edu].
- For how long will this data be available start date provided 30-11-2024 and end date provided 31-12-2025?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Sepsis is a life threatening illness in neonates, in both term and preterm babies. Neonatal sepsis accounts for about 8% of neonatal fatalities. This study aims to assess the value of lab based diagnostic indices as a predictor of Neonatal Sepsis in preterms. |